Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Validation of the EBMT Multiple Myeloma Early Relapse Score within Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study

Blood (2024) 144 (Supplement 1): 4733.

https://doi.org/10.1182/blood-2024-200071

Published: 2024

Journal Articles

Multiple Myeloma and Renal Impairment: Analysis of Induction Therapy Strategies and Outcome after Autologous Stem Cell Transplantation

Thomas Reiter, MD, Marlies Antlanger, Alexandra Böhm, Wolfgang Lamm, Max Gornicec, Ella Willenbacher, MD, David Nachbauer, Werner Rabitsch, Daniel Lechner, MD, Hildegard Greinix, Felix Keil, MD, Heinz Gisslinger, Hermine Agis, MD, Maria-Theresa Krauth, MD

Blood (2017) 130 (Supplement 1): 5424.

https://doi.org/10.1182/blood.V130.Suppl_1.5424.5424

Published: 2017

Journal Articles

Comparison of Allogeneic Stem Cell Transplantation for Transformed Acute Myeloid Leukemia Derived from MDS, CMML or MPN. a Report of the Chronic Malignancies Working Party of EBMT

Blood (2016) 128 (22): 3499.

https://doi.org/10.1182/blood.V128.22.3499.3499

Published: 2016

Journal Articles

Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease

Marie-Charlotte Brüggen, Irene Klein, Hildegard Greinix, Wolfgang Bauer, Zoya Kuzmina, Werner Rabitsch, Peter Kalhs, Peter Petzelbauer, Robert Knobler, Georg Stingl, Georg Stary

Blood (2014) 123 (2): 290–299.

https://doi.org/10.1182/blood-2013-07-514372

Published: 2014

Includes: Supplemental data

Journal Articles

Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study

Blood (2013) 121 (25): 5055–5063.

https://doi.org/10.1182/blood-2012-11-469452

Published: 2013

Journal Articles

Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial

Blood (2012) 119 (21): 4851–4859.

https://doi.org/10.1182/blood-2011-09-378505

Published: 2012

Includes: Supplemental data

Journal Articles

Validation of the NIH Criteria of the Severity Grading of Chronic Gvhd – Results of a Prospective German Multicenter Validation Trial.

Daniel Wolff, Philipp Herzberg, Pia Heussner, Friederike Mumm, Inken Hilgendorf, MD, Stephanie von Harsdorf, MD, Philipp Hemmati, Armin Gerbitz, MD, Michael Schmitt, Ernst Holler, PhD, Hildegard Greinix

Blood (2009) 114 (22): 204.

https://doi.org/10.1182/blood.V114.22.204.204

Published: 2009

Journal Articles

Assessment of the Potential of Immature CD19+CD21- B-Lymphocytes to Predict Response to Various Systemic Therapies in Chronic Graft-Versus-Host Disease.

Zoya Kuzmina, Hildegard Greinix, Roman Weigl, Sandra Eder, Robert Knobler, Ulrike Koermoeczi, Arno Rottal, Christoph C Zielinski, Winfried F. Pickl

Blood (2009) 114 (22): 2226.

https://doi.org/10.1182/blood.V114.22.2226.2226

Published: 2009

Journal Articles

Early Autologous Stem Cell Transplantation (autoSCT) May Overcome the Adverse Impact of Del 11q- in Poor-Risk Chronic Lymphocytic Leukemia (CLL): Results From the GCLLSG CLL3 Trial.

Peter Dreger, Hartmut Döhner, Hildegard Greinix, MD, Fabienne McClanahan, MD, Manfred Hensel, Bernd Hertenstein, Ulrich Dührsen, MD, PhD, Markus Hentrich, Lorenz Trümper, Ruth Sonnen, Bertold Emmerich, Wolfgang Ulrich Knauf, Georg Hopfinger, MD, Michael Hallek, Michael Kneba, MD, PhD, Norbert Schmitz, Stephan Stilgenbauer, MD

Blood (2009) 114 (22): 879.

https://doi.org/10.1182/blood.V114.22.879.879

Published: 2009

Journal Articles

Prospective Evaluation of An Agvhd-Specific Proteomic Pattern in More Than 340 Patients.

Eva M. Mischak-Weissinger, MD, Ernst Holler, PhD, Michael Schleuning, Gernot Beutel, Dr., Hildegard Greinix, Anne M Dickinson, PhD, James LM Ferrara, MD, Stefanie Buchholz, MD, Annika Krons, Julia Kontsendorn, Norbert Hahn, Axel R. Zander, Hans-Jochem Kolb, Jochen Metzger, PhD, Arnold Ganser, MD

Blood (2009) 114 (22): 347.

https://doi.org/10.1182/blood.V114.22.347.347

Published: 2009

Journal Articles

Tandem Autologous(ASCT)/ Allogeneic Reduced Intensity Conditioning Transplantation (RIC) with Identical Sibling Donor Versus ASCT in Previously Untreated Multiple Myeloma (MM): Long Term Follow up of a Prospective Controlled Trial by the EBMT.

Gosta Gahrton, MD, PhD, Bo Bjorkstrand, MD, PhD, Simona Iacobelli, Statistician, Ute Hegenbart, MD, Astrid Gruber, MD, PhD, Hildegard Greinix, MD, Liisa Volin, MD, Franco Narni, MD, Pellegrino Musto, MD, Meral Beksac, MD, Alberto Bosi, MD, Giuseppe Milone, MD, Paolo Corradini, MD, Hartmut Goldschmidt, MD, Theo de Witte, MD, Curly Morris, MD, Dietger Niederwieser, MD

Blood (2009) 114 (22): 52.

https://doi.org/10.1182/blood.V114.22.52.52

Published: 2009

Journal Articles

Mobilized Peripheral Blood Stem Cells (PBSC) Compared with Bone Marrow (BM) as the Stem Cell Source for Unrelated Donor Allogeneic Transplantation with Reduced Intensity Conditioning (RIC-alloSCT) in Patients with Acute Myeloid Leukemia (AML) in Complete Remission (CR): a Retrospective Analysis From the ALWP of EBMT.

Arnon Nagler, Myriam Labopin, Avichai Shimoni, Dietger Niederwieser, Nadezda Basara, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Axel R. Zander, Renate Arnold, MD, Hildegard Greinix, Jan J. Cornelissen, MD, PhD, Graham H Jackson, MD, Charles Craddock, BM, DPhil, FRCP, FRCPath, Donald W. Bunjes, MD, PhD, Arnold Ganser, MD, Nigel H. Russell, MD, Slawomira Kyrcz-Krzemien, Mohamad Mohty, MD, PhD, Vanderson Rocha, MD, PhD

Blood (2009) 114 (22): 527.

https://doi.org/10.1182/blood.V114.22.527.527

Published: 2009

Journal Articles

Proteomic Screening Applied to the Diagnosis of Chronic Graft-Versus-Host-Disease.

Eva M. Mischak-Weissinger, MD, Michael Stadler, MD, Ernst Holler, PhD, Michael Schleuning, Hildegard Greinix, MD, Hans-Jochem Kolb, MD, Anne M Dickinson, PhD, Annika Krons, Helmut Diedrich, MD, Julia Kontsendorn, Norbert Hahn, Jochen Metzger, PhD, Arnold Ganser, MD

Blood (2009) 114 (22): 1164.

https://doi.org/10.1182/blood.V114.22.1164.1164

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.

Blood (2009) 114 (22): 1209.

https://doi.org/10.1182/blood.V114.22.1209.1209

Published: 2009

Journal Articles

Monitoring of B Cell Subpopulations in Patients with Chronic Graft-Versus-Host Disease May Predict Response to Extracorporeal Photopheresis

Zoya Kuzmina, Winfried Pickl, Robert Knobler, Michal Kouba, Nina Worel, Georg Stary, Margit Mitterbauer, Peter Kalhs, Hildegard Greinix

Blood (2008) 112 (11): 467.

https://doi.org/10.1182/blood.V112.11.467.467

Published: 2008

Journal Articles

Factors Determining Survival after Unrelated Donor Stem Cell Transplantation in Primary Refractory Acute Myeloid Leukemia

Charles F. Craddock, BM, MRCP, MRCPath, Myriam Labopin, J. ürgen Finke, Gerhard Ehninger, MD, Donald Bunjes, Hans-Jochem Kolb, Hildegard Greinix, Axel Zander, Emmanuelle Polge, Christoph Schmid, Dietrich Beelen, Vanderson Rocha

Blood (2008) 112 (11): 564.

https://doi.org/10.1182/blood.V112.11.564.564

Published: 2008

Journal Articles

Improved Outcome for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Poor Risk Cytogenetics – Result from An Analysis on 172 Patients Receiving FLAMSA-RIC Conditioning for Allogeneic Stem Cell Transplantatioin (SCT).

Blood (2008) 112 (11): 1971.

https://doi.org/10.1182/blood.V112.11.1971.1971

Published: 2008

Journal Articles

Prospective Evaluation of the NIH Staging Criteria in Chronic GVHD and Correlation to Quality of Life - Results of a German Multicenter Validation Trial.

Daniel Wolff, MD, Philipp Y. Herzberg, Pia Heussner, MD, Friederike Mumm, MD, Stephanie von Harsdorf, MD, Katrin Rieger, MD, Hildegard Greinix, Joachim Hahn, MD, Ernst Holler, Mathias Freund

Blood (2007) 110 (11): 42.

https://doi.org/10.1182/blood.V110.11.42.42

Published: 2007

Journal Articles

Severe Donor Events after Allogeneic Hematopoietic Stem Cell Donation.

Jörg Halter, Yoshihisa Kodera, Alvaro Urbano Ispizua, Hildegard Greinix, Norbert Schmitz, Geneviève Favre, Helen Baldomero, Diegter Niederwieser, Jane Apperley, Alois Gratwohl

Blood (2007) 110 (11): 3276.

https://doi.org/10.1182/blood.V110.11.3276.3276

Published: 2007

Journal Articles

Adding Palifermin in Allogeneic and Autologous Stem Cell Transplantation Resulted in Reduced Oral Mucositis and Enhanced Intestinal Mucosal Recovery Measured by Citrulline Serum Levels.

Stefan Langner, MD, Philipp B. Staber, MD, Armin Zebisch, MD, Wilma Zinke-Cerwenka, MD, Heinz Sill, MD, Werner Linkesch, MD, Hildegard Greinix, MD, Peter Kalhs, MD, Werner Rabitsch, MD, Peter Neumeister, MD

Blood (2006) 108 (11): 5251.

https://doi.org/10.1182/blood.V108.11.5251.5251

Published: 2006

NARROW

Validation of the EBMT Multiple Myeloma Early Relapse Score within Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study

Multiple Myeloma and Renal Impairment: Analysis of Induction Therapy Strategies and Outcome after Autologous Stem Cell Transplantation

Comparison of Allogeneic Stem Cell Transplantation for Transformed Acute Myeloid Leukemia Derived from MDS, CMML or MPN. a Report of the Chronic Malignancies Working Party of EBMT

Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease

Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study

Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial

Validation of the NIH Criteria of the Severity Grading of Chronic Gvhd – Results of a Prospective German Multicenter Validation Trial.

Assessment of the Potential of Immature CD19+CD21- B-Lymphocytes to Predict Response to Various Systemic Therapies in Chronic Graft-Versus-Host Disease.

Early Autologous Stem Cell Transplantation (autoSCT) May Overcome the Adverse Impact of Del 11q- in Poor-Risk Chronic Lymphocytic Leukemia (CLL): Results From the GCLLSG CLL3 Trial.

Prospective Evaluation of An Agvhd-Specific Proteomic Pattern in More Than 340 Patients.

Tandem Autologous(ASCT)/ Allogeneic Reduced Intensity Conditioning Transplantation (RIC) with Identical Sibling Donor Versus ASCT in Previously Untreated Multiple Myeloma (MM): Long Term Follow up of a Prospective Controlled Trial by the EBMT.

Proteomic Screening Applied to the Diagnosis of Chronic Graft-Versus-Host-Disease.

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.

Monitoring of B Cell Subpopulations in Patients with Chronic Graft-Versus-Host Disease May Predict Response to Extracorporeal Photopheresis

Factors Determining Survival after Unrelated Donor Stem Cell Transplantation in Primary Refractory Acute Myeloid Leukemia

Improved Outcome for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Poor Risk Cytogenetics – Result from An Analysis on 172 Patients Receiving FLAMSA-RIC Conditioning for Allogeneic Stem Cell Transplantatioin (SCT).

Prospective Evaluation of the NIH Staging Criteria in Chronic GVHD and Correlation to Quality of Life - Results of a German Multicenter Validation Trial.

Severe Donor Events after Allogeneic Hematopoietic Stem Cell Donation.

Adding Palifermin in Allogeneic and Autologous Stem Cell Transplantation Resulted in Reduced Oral Mucositis and Enhanced Intestinal Mucosal Recovery Measured by Citrulline Serum Levels.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only